Skip to main content

Table 1 Baseline characteristics of PMO study population, June 2005 – May 2010

From: Predictive values of diagnostic codes for identifying serious hypocalcemia and dermatologic adverse events among women with postmenopausal osteoporosis in a commercial health plan database

Characteristics

Number of patients (%)

N = 165,729

Age (years)

 55 to 64

130,344 (78.6)

 65 to 69

17,348 (10.5)

 70 to 74

7966 (4.8)

  ≥ 75

10,071 (6.1)

Race

 Asian

3898 (2.4)

 Caucasian

123,788 (74.7)

 Hispanic

10,131 (6.1)

 Black

12,579 (7.6)

 Other

1200 (0.7)

 Unknown

14,077 (8.5)

Geographic region

 Northeast

14,124 (8.5)

 Midwest

35,746 (21.6)

 South

98,519 (59.4)

 West

16,965 (10.2)

 Unknown

375 (0.2)

Calendar year of cohort entry

 2005

49,311 (29.8)

 2006

34,899 (21.1)

 2007

26,828 (16.2)

 2008

28,508 (17.2)

 2009

20,390 (12.3)

 2010

5793 (3.5)

Usage of healthcare facilities

 Patients with at least one physician office/outpatient visit

154,648 (93.3)

 Patients with at least one emergency room visit

28,381 (17.1)

 Patients with at least one hospitalization

11,472 (6.9)

  1. Abbreviation: PMO Post-Menopausal Osteoporosis